Jim Continenza, CEO of Kodak, explains why the onetime photography leader is well positioned to produce pharmaceuticals. The company will receive a $765 million government loan to make pharmaceutical ingredients.

TownNews.com Content Exchange

Tags

TownNews.com Content Exchange